FGF19 and metabolic disease: FGF19 has shown beneficial effects on the obese metabolic profile (i.e., increased energy expenditure and weight loss after chronic treatment, improved lipid profile) mediated via white adipose tissue metabolism [20], but the stimulation of proliferation by FGF19 in liver currently prevents its use to treat metabolic diseases [21].